These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2468996)

  • 1. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.
    Gumucio DL; Rood KL; Gray TA; Riordan MF; Sartor CI; Collins FS
    Mol Cell Biol; 1988 Dec; 8(12):5310-22. PubMed ID: 2468996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors.
    Mantovani R; Malgaretti N; Nicolis S; Ronchi A; Giglioni B; Ottolenghi S
    Nucleic Acids Res; 1988 Aug; 16(16):7783-97. PubMed ID: 2458563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequences regulating human globin gene transcription in nondeletional hereditary persistence of fetal hemoglobin.
    Ottolenghi S; Mantovani R; Nicolis S; Ronchi A; Giglioni B
    Hemoglobin; 1989; 13(6):523-41. PubMed ID: 2481658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites I and II upstream of the A gamma globin gene bind nuclear factors and affect gene expression.
    Lloyd JA; Lee RF; Menon AG; Lingrel JB
    Prog Clin Biol Res; 1989; 316A():139-48. PubMed ID: 2480607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.
    Jane SM; Gumucio DL; Ney PA; Cunningham JM; Nienhuis AW
    Mol Cell Biol; 1993 Jun; 13(6):3272-81. PubMed ID: 7684493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.
    Rixon MW; Gelinas RE
    Mol Cell Biol; 1988 Feb; 8(2):713-21. PubMed ID: 2451123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor.
    Martin DI; Tsai SF; Orkin SH
    Nature; 1989 Mar; 338(6214):435-8. PubMed ID: 2467208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.
    Fischer KD; Nowock J
    Nucleic Acids Res; 1990 Oct; 18(19):5685-93. PubMed ID: 1699206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deletion of the distal CCAAT box region of the A gamma-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein.
    Mantovani R; Superti-Furga G; Gilman J; Ottolenghi S
    Nucleic Acids Res; 1989 Aug; 17(16):6681-91. PubMed ID: 2476717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the duplicated CCAAT box region in gamma-globin gene regulation and hereditary persistence of fetal haemoglobin.
    Ronchi A; Berry M; Raguz S; Imam A; Yannoutsos N; Ottolenghi S; Grosveld F; Dillon N
    EMBO J; 1996 Jan; 15(1):143-9. PubMed ID: 8598197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the distal CCAAT box of the gamma-globin gene in Hb switching.
    Katsube T; Fukumaki Y
    J Biochem; 1995 Jan; 117(1):68-76. PubMed ID: 7539789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the human fetal-to-adult globin switching.
    Katsube T; Fucharoen S; Tojo H; Fukumaki Y
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():212-20. PubMed ID: 8629109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
    Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
    J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -175T----C mutation increases promoter strength in erythroid cells: correlation with evolutionary conservation of binding sites for two trans-acting factors.
    Gumucio DL; Lockwood WK; Weber JL; Saulino AM; Delgrosso K; Surrey S; Schwartz E; Goodman M; Collins FS
    Blood; 1990 Feb; 75(3):756-61. PubMed ID: 1688723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice.
    Liu LR; Du ZW; Zhao HL; Liu XL; Huang XD; Shen J; Ju LM; Fang FD; Zhang JW
    J Biol Chem; 2005 Mar; 280(9):7452-9. PubMed ID: 15613485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G gamma A gamma (beta+) hereditary persistence of fetal hemoglobin: the G gamma -158 C-->T mutation in cis to the -175 T-->C mutation of the A gamma-globin gene results in increased G gamma-globin synthesis.
    Coleman MB; Adams JG; Steinberg MH; Plonczynski MW; Harrell AH; Castro O; Winter WP
    Am J Hematol; 1993 Feb; 42(2):186-90. PubMed ID: 7679879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and identification of proteins that bind to the hereditary persistence of fetal hemoglobin -198 mutation in the gamma-globin gene promoter.
    Olave IA; Doneanu C; Fang X; Stamatoyannopoulos G; Li Q
    J Biol Chem; 2007 Jan; 282(2):853-62. PubMed ID: 17114178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-globin gene promoter elements required for interaction with globin enhancers.
    Langdon SD; Kaufman RE
    Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The -117 mutation in Greek HPFH affects the binding of three nuclear factors to the CCAAT region of the gamma-globin gene.
    Superti-Furga G; Barberis A; Schaffner G; Busslinger M
    EMBO J; 1988 Oct; 7(10):3099-107. PubMed ID: 3181130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
    Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
    Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.